2022 was an incredibly productive year for American scientists. Biopharmaceutical researchers conducted over 7,000 clinical programs, including more than 3,000…
adminFebruary 13, 2023
Dear scientific community, The European programme ApogeeBio has launched the 2nd international call for 12 postdoctoral positions in Genopole biocluster,…
adminFebruary 13, 2023
KaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution to the high need for treating trauma in…
adminFebruary 13, 2023
BHI EIR Feedback Day – February 15 This free 1:1 virtual session is an opportunity…
adminFebruary 6, 2023
Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to…
adminFebruary 6, 2023
Stronger sales in Europe and the U.S. helped offset declining demand in Japan for the Medical Business Unit of Japanese…
adminFebruary 6, 2023
⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January 31, 2023 – Cartesian Therapeutics, a fully integrated,…
adminFebruary 6, 2023
AURP’s BioHealth Caucus will examine topics, including: Economic impact of the biotech industry in the U.S. New biotech hubs growing…
adminFebruary 6, 2023
The newly established Advanced Research Projects Agency for Health (ARPA-H) will accelerate cutting-edge biomedical and health research, moving discoveries from…
adminFebruary 6, 2023